Does BORTEZOMIB Cause Thrombotic microangiopathy? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Thrombotic microangiopathy have been filed in association with BORTEZOMIB (bortezomib). This represents 0.3% of all adverse event reports for BORTEZOMIB.
147
Reports of Thrombotic microangiopathy with BORTEZOMIB
0.3%
of all BORTEZOMIB reports
39
Deaths
85
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From BORTEZOMIB?
Of the 147 reports, 39 (26.5%) resulted in death, 85 (57.8%) required hospitalization, and 26 (17.7%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for BORTEZOMIB.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which BORTEZOMIB Alternatives Have Lower Thrombotic microangiopathy Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX